Sandbox:Sonya: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (26 intermediate revisions by the same user not shown) | |||
| Line 12: | Line 12: | ||
===Indication=== | ===Indication=== | ||
*[[Lyme disease]] | |||
*[[Coronary heart disease]] | |||
[[ | ==Warnings== | ||
=====Diarrhea===== | |||
*'''[[Diarrhea]]''' occurred in 85% of patients receiving drug X | |||
=====Fatigue===== | |||
*'''[[Fatigue]]''' occurred in 90% of ''adult patients'' within 2-5 hours of receiving drug X | |||
=====Blurred Vision===== | |||
*'''[[Blurred vision]]''' occurred in 73% of patients receiving drug X | |||
==Brand Names== | |||
#Brand name Y | |||
##Available in the US | |||
##Available in Canada | |||
##Available in the UK | |||
#Brand name Z | |||
==Determining Dosage== | |||
{| border="1" cellpadding="2" | |||
!width="50"|Age | |||
!width="225"|Dosage | |||
!width="225"|Dose per hour | |||
|- | |||
|20-39 || 50mg || 1 dose every 12 hours | |||
|- | |||
|40-59 || 150mg || 1 dose every 6 hours | |||
|- | |||
|60+ || 100mg || 1 dose every 4 hours | |||
|} | |||
==Trying Out Different Colors Through Addition== | |||
{| class="wikitable" style="text-align:center" | |||
|''+Addition Table'' | |||
{| style="background:#CD5C5C; " | |||
|- | |||
! + !! 1 !! 2 !! 3 | |||
|- | |||
! '''1''' | |||
| 2 || 3 || 4 | |||
|- | |||
! '''2''' | |||
| 3 || 4 || 5 | |||
|- | |||
! '''3''' | |||
| 4 || 5 || 6 | |||
|- | |||
! '''4''' | |||
| 5 || 6 || 7 | |||
|- | |||
! '''5''' | |||
| 6 || 7 || 8 | |||
|} | |||
|} | |||
==Flow Chart== | |||
{{Family tree/start}} | |||
{{Family tree | | | | | | | A01 | | | | | | | | | | A01=Computers}} | |||
{{Family tree | | | |,|-|-|-|^|-|-|-|.| | | | | | | }} | |||
{{Family tree | | | B01 | | | | | | B02 | | | | | | B01=Macbook|B02=Windows}} | |||
{{Family tree | |,|-|^|-|.| | | |,|-|^|-|.| | | | |}} | |||
{{Family tree | C01 | | C02 | | C03 | | C04 | | | | C01=Good|C02=Bad|C03=Good|C04=Bad}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree/end}} | |||
Latest revision as of 13:21, 11 July 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sonya Gelfand
Overview
Dosage and Indications
Dosage
- Twice daily
- Per oral
- May be give in IV form
Indication
Warnings
Diarrhea
- Diarrhea occurred in 85% of patients receiving drug X
Fatigue
- Fatigue occurred in 90% of adult patients within 2-5 hours of receiving drug X
Blurred Vision
- Blurred vision occurred in 73% of patients receiving drug X
Brand Names
- Brand name Y
- Available in the US
- Available in Canada
- Available in the UK
- Brand name Z
Determining Dosage
| Age | Dosage | Dose per hour |
|---|---|---|
| 20-39 | 50mg | 1 dose every 12 hours |
| 40-59 | 150mg | 1 dose every 6 hours |
| 60+ | 100mg | 1 dose every 4 hours |
Trying Out Different Colors Through Addition
+Addition Table
|
Flow Chart
| Computers | |||||||||||||||||||||||||||||||||||||
| Macbook | Windows | ||||||||||||||||||||||||||||||||||||
| Good | Bad | Good | Bad | ||||||||||||||||||||||||||||||||||